Ignite Creation Date:
2024-05-05 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00419796
Status:
COMPLETED
Last Update Posted:
2007-11-29
First Post:
2007-01-08
Brief Title:
Effects of Lumiracoxib and Ibuprofen on Blood Pressure and Urinary Eicosanoid Excretion in Osteoarthritis Patients With Controlled Hypertension
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A 4-Week Multicentre Randomized Double-Blind Placebo Controlled Double Dummy Parallel Group Study to Assess the Effect of Lumiracoxib 100 mg od and Ibuprofen 600 mg tid on 24-Hour Blood Pressure Profile and on Urinary Excretions of Eicosanoids in Osteoarthritis Patients With Controlled Hypertension
Status:
COMPLETED
Status Verified Date:
2007-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This randomized study will compare the effect of lumiracoxib ibuprofen and placebo on 24-hour blood pressure profile and on urinary excretions of eicosanoids in controlled hypertensive patients who have osteoarthritis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None